We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

12 hedge funds and large institutions have $9.34M invested in Virtus Biotech ETF in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.44% less ownership

Funds ownership: 42% → 41.56% (-0.44%)

21% less capital invested

Capital invested by funds: $11.9M → $9.34M (-$2.53M)

29% less funds holding

Funds holding: 17 → 12 (-5)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$759K
2
UBS Group
UBS Group
Switzerland
+$9.63K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$835K
2
AWCI
Alpine Woods Capital Investors
New York
-$370K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$217K
4
Citadel Advisors
Citadel Advisors
Florida
-$124K
5
SMG
Smart Money Group
Texas
-$81.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$4.81M +$759K +18,357 +17%
SMG
2
Smart Money Group
Texas
$2.25M -$81.5K -1,970 -3%
Jane Street
3
Jane Street
New York
$680K -$835K -20,184 -53%
FAIM
4
Financial Advocates Investment Management
Washington
$436K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$353K -$124K -3,000 -24%
LPL Financial
6
LPL Financial
California
$302K -$80.4K -1,945 -19%
Stifel Financial
7
Stifel Financial
Missouri
$288K -$4.13K -100 -1%
Morgan Stanley
8
Morgan Stanley
New York
$69K -$41 -1 -0.1%
UBS Group
9
UBS Group
Switzerland
$63K +$9.63K +233 +16%
Osaic Holdings
10
Osaic Holdings
Arizona
$60K +$66.6K +1,611 New
FWM
11
Focused Wealth Management
New York
$26K – – –
CFB
12
Cullen/Frost Bankers
Texas
$3K – – –
AWCI
13
Alpine Woods Capital Investors
New York
– -$370K -8,500 Closed
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
– -$217K -4,989 Closed
CFA
15
Carroll Financial Associates
North Carolina
– -$11K -253 Closed
Bank of America
16
Bank of America
North Carolina
– -$4K -85 Closed

BBP Hedge Fund Activity: Q1 2020 in Review

12 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2020, worth a combined $9.34M — down 21% from $11.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BBP and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 2 added.

The largest buyer was Royal Bank of Canada, adding an estimated $759K. The largest seller was Jane Street, cutting an estimated $835K.

  • 12 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2020, down from 17 in Q4 2019.
  • Funds reported $9.34M of Virtus Biotech ETF stock for Q1 2020, down 21% quarter-over-quarter.
  • 1 fund opened new Virtus Biotech ETF positions in Q1 2020 and 4 closed out, a net change of -3 holders.
  • The largest Virtus Biotech ETF buyer in Q1 2020 was Royal Bank of Canada, an estimated $759K added.
  • The largest Virtus Biotech ETF seller in Q1 2020 was Jane Street, an estimated $835K sold.

Based on aggregated 13F filings for Q1 2020.